Article info
PDFClinical science
Intraocular methotrexate for epithelial downgrowth: long-term outcomes in a multicentre case series
- Correspondence to Dr Marie Eve Légaré, Department of Ophthalmology, Centre Hospitalier affilié Universitaire de Québec Hôpital du Saint-Sacrement, Quebec, Canada; marie-eve.legare{at}fmed.ulaval.ca
Citation
Intraocular methotrexate for epithelial downgrowth: long-term outcomes in a multicentre case series
Publication history
- Received January 28, 2022
- Accepted May 15, 2022
- First published June 1, 2022.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.